Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
Anti-Aquaporin 4 Antibody
Our Anti-Aquaporin 4 rabbit polyclonal primary antibody from PhosphoSolutions is produced in-house.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P47863 |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Calculated MW | 34480 Da |
| Gene ID | 25293 |
|---|---|
| Other Names | AQP 4 antibody, AQP-4 antibody, AQP4 antibody, AQP4_HUMAN antibody, Aquaporin type 4 antibody, Aquaporin-4 antibody, Aquaporin4 antibody, HMIWC 2 antibody, HMIWC2 antibody, Mercurial insensitive water channel antibody, Mercurial-insensitive water channel antibody, MGC22454 antibody, MIWC antibody, WCH 4 antibody, WCH4 antibody |
| Target/Specificity | Aquaporin-4 (AQP4), a bidirectional water channel protein, is the most expressed aquaporin within the central nervous system. AQP4 is predominantly expressed by astrocytes and ependymal cells within the blood-brain-barrier and ependymal-cerebrospinal fluid barriers (Verkman, et al 2011). AQP4 plays a role in synaptic plasticity (Skucas et al, 2011), astrocyte mitigation (Saadoun et al, 2005), and K+ homeostasis (Binder et al, 2006). Due to the significant role AQP4 plays in cognition, it has been reported to be dysregulated in several neurological disorders. Alzheimer’s patients have amyloid deposits in the walls of the vasculature known as CAA which causes AQP4 mis-location (Wilcock et al, 2009). Patients with Parkinson’s disease have low levels of AQP4 expression which leads to reduced inflammatory response (Chi et al,2011). Reduced levels of AQP4 in traumatic brain injury affects both the acute stage, decreasing the ability to remove excess water from the brain, and in the later stage, by preventing cellular damage and swelling (Zhang et al, 2015). |
| Format | Antigen Affinity Purified from Pooled Serum |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Precautions | Anti-Aquaporin 4 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
| Shipping | Blue Ice |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Aquaporin-4 (AQP4), a bidirectional water channel protein, is the most expressed aquaporin within the central nervous system. AQP4 is predominantly expressed by astrocytes and ependymal cells within the blood-brain-barrier and ependymal-cerebrospinal fluid barriers (Verkman, et al 2011). AQP4 plays a role in synaptic plasticity (Skucas et al, 2011), astrocyte mitigation (Saadoun et al, 2005), and K+ homeostasis (Binder et al, 2006). Due to the significant role AQP4 plays in cognition, it has been reported to be dysregulated in several neurological disorders. Alzheimer’s patients have amyloid deposits in the walls of the vasculature known as CAA which causes AQP4 mis-location (Wilcock et al, 2009). Patients with Parkinson’s disease have low levels of AQP4 expression which leads to reduced inflammatory response (Chi et al,2011). Reduced levels of AQP4 in traumatic brain injury affects both the acute stage, decreasing the ability to remove excess water from the brain, and in the later stage, by preventing cellular damage and swelling (Zhang et al, 2015).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
